![](https://static.wixstatic.com/media/3fea9e_cacb9951b001427c979d16b1898bb2b5~mv2.png/v1/crop/x_0,y_152,w_2468,h_2229/fill/w_195,h_176,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/3fea9e_cacb9951b001427c979d16b1898bb2b5~mv2.png)
11th NPC Research Day 2023
& 13th NPCSM AGM
![Dr. Xavier.jpg](https://static.wixstatic.com/media/3fea9e_65bf18c1fb77405082ab60c4aee34e8a~mv2.jpg/v1/fill/w_140,h_198,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/Dr_%20Xavier.jpg)
Dr Xavier Chee Wezen
Swinburne University of Technology (Sarawak Campus), Malaysia
​
Xavier received his BSc in Chemistry (Hons) from the Department of Chemistry, Imperial College London, UK in 2014. Subsequently, he did his PhD with Dr Taufiq Rahman in the Department of Pharmacology, University of Cambridge, UK focusing on finding new antibiotics using computational drug discovery methods. After completing his PhD in 2017, Xavier decided to take break from research and went to teach Chemistry in an international school in his hometown Sibu. Later, he joined the School of Engineering & Science, Swinburne University of Technology Sarawak as a lecturer in 2019.
​
His research interests include using computational drug discovery methods, molecular dynamics simulation and machine learning to find new chemicals compounds against different drug targets to treat diseases. Nowadays, his focus is on designing dual-inhibitors against various therapeutic targets.